Angiogenically active vascular endothelial growth factor is over-expressed in malignant human and rat prostate carcinoma cells

British Journal of Cancer

Volumn 82, Issue 10, 2000, Pages 1694-1701

  Chen, H J ^a   Treweeke, A T ^a   Ke, Y Q ^a   West, D C ^a   Toh, C H ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Isoforms; Metastasis; Over expression; Prostatic cell lines; Vascular endothelial growth factor

Indexed keywords

DNA; MESSENGER RNA; NUCLEOTIDE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL LINE; CHICKEN; CHORIOALLANTOIS; CONTROLLED STUDY; DNA TRANSCRIPTION; DNA TRANSFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; MALE; METASTASIS; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE TUMOR; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ALLANTOIS; ANIMALS; CHICK EMBRYO; CHORION; ENDOTHELIAL GROWTH FACTORS; HUMANS; LYMPHOKINES; MALE; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NEOVASCULARIZATION, PHYSIOLOGIC; PROSTATE; PROSTATIC NEOPLASMS; RATS; RNA, MESSENGER; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034057340     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Alwine JC, Kemp DJ and Stark G (1977) Methods for the detection of specific RNAs in agarose gel by transfer to diazobenzy methyl-paper and hybridization with DNA probes. Proc Natl Acad Sci USA 12: 5350-5354
2. Balbay MD, Pettaway CA, Kuniyasu H, Inoue K, Ramirez E, Li E, Fidler IJ and Dinney CPN (1999) Highly metastatic human prostate cancer growing within the prostate of athymic mice overexpression vascular endothelial growth factor. Clin Cancer Res 5: 783-789
3. Battegay EJ (1995) Angiogenesis-mechanistic insights, neovascular diseases, and therapeutic prospects. J Mol Med 73: 333-346
4. Berthon P, Cussenot O, Hopwood I, Leduc A and Maitland NJ (1995) Functional expression of SV40 in normal human prostatic epithelial and fibroblastic cells -differentiation pattern of non-tumorigenic cell-lines. Int J Oncol 6: 333-343
5. Connolly JM and Rose DP (1998) Angiogenesis in two human prostate cancer cell lines with differing metastatic potential when growing as solid tumors in nude mice. J Urol 160: 932-936
6. Crew JP, O'Brien T, Bradburn M, Fuggle S, Bicknell R, Cranston D and Harris AL (1997) Vascular endothelial growth factor is a predictor of relapse and stage progression in superficial bladder cancer. Cancer Res 57: 5281-5285
7. Cussenot O, Berthon P, Berger R, Mowsowixz I, Faille A, Hojman F, Teillac P, Leduc A and Calvo F (1991) Immortalization of human adult normal prostatic epithelial-cells by Liposomes containing Large T-SV40 gene. J Urol 146: 881-886
8. Cussenot O, Berthon P, Cochandpriollet S. Maitland NJ and Leduc A (1994) Immunocytochemical comparison of cultured normal epithelial prostatic cells with prostatic tissue-sections. Exp Cell Res 214: 83-92
9. Deshmukh N, Scotson J, Dodson AR, Ke Y and Foster CS (1997) Differential expression of acidic-and basic-FGF in benign prostatic hyperplasia identified by immunohistochemistry. Br J Urol 80: 869-874
10. Dirix LY, Vermeulen PB, Hubens G, Benoy I, Martin M, De Pooter C and Van Oosterom AT (1996) Serum basic fibroblast growth factor and vascular endothelial growth factor and tumour growth kinetics in advanced colorectal cancer. Ann Oncol 7: 843-848
11. Dunnington DJ, Kim U, Hughes CM, Monaghan P, Ormerod J and Rudland PS (1983) Phenotypic instability of rat mammary tumor epithelial cells. J Natl Cancer lnst 7: 1227-1240
12. Duque JLF, Loughlin KR, Adam RM, Kantoff PW, Zurakowski D and Freeman MR (1999) Plasma levels of vascular endothelial growth factor are increased in patients with metastatic prostate cancer. Urol 54: 523-527
13. Ferrer FA, Miller LJ, Andrawis RI, Kurtzman SH, Albertson PC, Laudone VP and Kreutzer DL (1997) Vascular endothelial growth factor (VEGF) expression in human prostate cancer: in situ and in vitro expression of VEGF by human prostate cancer cells. J Urol 157: 2329-2333
14. Ferrer FA, Miller LJ, Andrawis RI, Kurtzman SH, Albertson PC, Laudone VP and Kreutzer DL (1998) Angiogenesis and prostate cancer: in vivo and in vitro expression of angiogenesis factors by protate cancer cells. Urol 51: 161-167
15. Foster CS (1990) Predictive factors in prostatic hyperplasia and neoplasia. Hum Pathol 21: 575-577
16. Foster CS and Abel PD (1992) Clinical and molecular techniques for diagnosis and monitoring of prostatic cancer. Hum Pathol 23: 395-401
17. Fukumura D, Xavier R, Sugiura T, Chen Y, Park EC, Lu N, Selig M, Nielsen G, Taksir T, Jain R and Seed B (1998) Tumor induction of VEGF promoter activity in stromal cells. Cell 94: 715-725
18. Geller J (1995) Approach to chemoprevention of prostate-cancer. J Clin Endocrinol Met 80: 717-719
19. Haggstrom S, Wikstrom P, Bergh A and Damber JE (1998) Expression of vascular endothelial growth factor and its receptors in the rat ventral prostate and Dunning R3327 PAP adenocarcinoma before and after castration. Prostate 36: 71-79
20. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Miranol EA and Murphy GP (1983) LNcap model of human prostatic-carcinoma. Cancer Res 43: 1809-1818
21. Houck KA, Ferrara N, Winer J, Cachianes G, Li B and Leung DW (1991) The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 5: 1806-1814
22. Isaacs JT, Issaacs WB, Feitz WFJ and Scheres J (1986) Establishment and characterization of seven Dunning rat prostatic cancer cell-lines and their use in developing methods for predicting metastatic abilities of prostatic cancer. Prostate 9: 261-281
23. Jackson MW, Bentel JM and Tilley WD (1997) Vascular endothelial growth factor (VEGF) expression in prostate cancer and benign prostatic hyperplasia. J Urol 157: 2323-2328
24. Kaighn ME, Narayan S, Ohnuki Y, Lechner JF and Jones LW (1979) Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 17: 16-23
25. Ke Y, Beesley C, Smith, Barraclough R, Rudland PS and Foster CS (1998) Generation of metastatic variants by transfection of a rat non-metastatic epithelial cell line with genomic DNA from rat prostatic carcinoma cells. Br J Cancer 77: 287-296
26. Kraft A, Weindel K, Ochs A, Marth C, Zmiji J, Schumacher P, Unger C, Marme D and Gastl G (1999) Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant diseases. Cancer 85: 178-18
27. Liotta LA, Steeg PS, Stetler-Stevenson WG (1991) Cancer metastasis and angiogenesis: an inbalance of positive and negative regulation. Cell 64: 327-336
28. Melnyk O, Zimmerman M, Kim KJ and Shuman M (1999) Neutralising anti-vascular endothelial growth factor antibody inhibits further growth of established prostate cancer and metastasis in a pre-clinical model. J Urol 161: 960-963
29. Molica S, Vitelli G, Levato D, Gandolfo GM and Liso V (1999) Increased serum levels of vascular endothelial growth factor predict risk of progression in early B-cell chronic lymphocytic leukaemia. Br J Haematol 107: 605-610
30. 145. a secreted vascular endothelial growth factor isoform that binds to extracellular matrix. J Biol Chem 272: 7151-7158
31. Salven P, Maenpaa H, Orpana A, Alitalo K and Joensuu H (1997) Serum VEGF is often elevated in disseminated cancer. Clin Cancer Res 6: 647-651
32. Shima DT, Adamis AP, Ferrara N, Yeo KT, Allende R, Folkman J and Damore PA (1995) Hypoxic induction of endothelial-cell growth-factors in retinal cells -identification and characterization of vascular endothelial growth-factor (VEGF) as the mitogen. Mol Med 2: 64-71
33. Stephan CC and Brock TA (1996) Vascular endothelial growth factor, a multifunctional polypeptide. Puerto Rico Health Sci J 15: 169-178
34. Stone KR, Mickey DD, Wunderli H, Mickey GH and Paulson DF (1978) Isolation of a human prostate carcinoma cell line (DU-145). Int J Cancer 21: 274-281
35. Tischer E, Mitcher R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC and Abraham JA (1991) The human gene for vascular endothelial growth factor, multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266: 11947-11954
36. Tokunaga T, Oshika Y, Abe Y, Ozeki Y, Sadahiro S, Kijima H, Tsuchida T, Yamazaki H, Ueyama Y, Tamaoki N and Nakamura M (1998) Vascular endothelial growth faclor (VEGF) mRNA isoform expression pattern is associated with liver metastasis and poor prognosis in colon cancer. Br J Cancer 77: 998-1002
37. Weidner N (1995) Intratumor microvessel density as prognostic factor in cancer. Am J Pathol 147: 9-15
38. West DC, Hampson IN, Arnold F and Kumar S (1985) Angiogenesis induced by degradation products of hyaluronic-acid. Science 228: 1324-1326